Individuals with pathogenic changes in the NF2 gene, which encodes merlin, a cytoskeletal linker protein that regulates Hippo–YAP signaling (Petrilli and Fernandez-Valle, 2016), can develop benign nerve sheath tumors called schwannomas anywhere in the body. The gene discussed is NF2; the disease is schwannoma.